Itraconazole (200 mg)
Sponsors
H. Lundbeck A/S, Lomond Therapeutics Holdings, Inc., Immunome, Inc., Urooj Fatima
Conditions
AMLCytochrome P450 InteractionDermatophytosisHealthyHealthy VolunteerTinea Corporis
Phase 1
Study Evaluating the Effect of Multiple Doses of Itraconazole on the Drug Lu AF35700 in Healthy Young Men and Women
CompletedNCT03103646
Start: 2017-03-28End: 2019-07-19Updated: 2019-10-02
Study of Single and Multiple Ascending Doses of ZE46-0134 in Healthy Volunteers
CompletedNCT06399315
Start: 2023-07-28End: 2025-08-26Updated: 2025-12-09
A Phase 1 Study to Examine the Effects of Itraconazole After Single Dose Administration of Varegacestat (AL102) to Healthy Participants
CompletedNCT06677996
Start: 2024-11-11End: 2025-05-07Updated: 2025-05-11
Clinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Administration of ZE50-0134 at 5 Dose Levels in Healthy Volunteers
CompletedNCT06787131
Start: 2024-05-21End: 2025-07-04Updated: 2025-12-05